5 rezultatima
FIELD OF THE INVENTION
The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions
FIELD OF THE INVENTION
The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to RTVP genes and associated sequences, to RTVP proteins, and to methods and tools using these sequences for the diagnosis, study and treatment of disease. Further, the invention includes RTVP receptor protein and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to RTVP genes and associated sequences, to RTVP proteins, and to methods and tools using these sequences for the diagnosis, study and treatment of disease. Further, the invention includes RTVP receptor protein and
This application is in the area of pharmaceutical chemistry, and in particular includes sphingolipid derivatives, prodrugs and pharmaceutical compositions and salts thereof for the treatment of abnormal cell proliferation, including benign and malignant tumors, the promotion of cell differentiation,